Compare CCEL & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | NMTC |
|---|---|---|
| Founded | 1989 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 34.3M |
| IPO Year | 2022 | 2010 |
| Metric | CCEL | NMTC |
|---|---|---|
| Price | $3.37 | $0.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $2.23 |
| AVG Volume (30 Days) | 12.5K | ★ 210.3K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 4.45% | N/A |
| EPS Growth | ★ 104.39 | 80.43 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $25,384,279.00 | $9,097,692.00 |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | $32.08 |
| P/E Ratio | $19.82 | ★ N/A |
| Revenue Growth | 9.76 | ★ 163.47 |
| 52 Week Low | $3.10 | $0.40 |
| 52 Week High | $7.91 | $1.15 |
| Indicator | CCEL | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 40.54 |
| Support Level | $3.33 | $0.57 |
| Resistance Level | $3.57 | $0.72 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 68.87 | 15.10 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.